Loading chat...
NJ A1636
Bill
Status
1/13/2026
Primary Sponsor
Sean Kean
Click for details
AI Summary
-
Classifies 7-Hydroxymitragynine (7-OH), a psychoactive alkaloid found in kratom, as a Schedule I controlled dangerous substance in New Jersey, defining it as having high abuse potential and no accepted medical use
-
Prohibits the sale, distribution, and manufacture of any product containing 7-OH, with manufacturers and distributors required to issue immediate recalls for affected products
-
Requires retailers to remove recalled products within 48 hours of notice and return inventory to manufacturers/distributors within 30 business days at the manufacturer's expense
-
Establishes escalating criminal penalties for violations: fourth-degree crime for first offense (up to 18 months imprisonment, $10,000 fine), third-degree for second offense, and second-degree for third or subsequent offenses (5-10 years, up to $150,000 fine)
-
Follows FDA recommendations from July 29, 2025 to schedule 7-OH, citing concerns that concentrated products sold in gas stations, vape shops, and online can contain up to 500% more 7-OH than naturally occurs in kratom and may be as addictive as opioids
Legislative Description
Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.
Consumer Affairs
Last Action
Introduced, Referred to Assembly Consumer Affairs Committee
1/13/2026